Multiple sclerosis is associated with psoriasis. A case-control study

Journal of the Neurological Sciences

Volumn 338, Issue 1-2, 2014, Pages 226-228

  Fellner, Avi ^a   Dano, Marina ^b   Regev, Keren ^b   Mosek, Amnon ^b   Karni, Arnon ^b,c  

^a Belinson Hospital   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Autoimmune disease; Co morbid patients; Interferon beta; Multiple sclerosis; Psoriasis; T cell mediated disease

Indexed keywords

BETA INTERFERON;

ADULT; ARTICLE; CASE CONTROL STUDY; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE EXACERBATION; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PSORIASIS;

AUTOIMMUNE DISEASE; CO-MORBID PATIENTS; INTERFERON-BETA; MULTIPLE SCLEROSIS; PSORIASIS; T CELL MEDIATED DISEASE;

ADULT; CASE-CONTROL STUDIES; DISABILITY EVALUATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PSORIASIS;

EID: 84896728594     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2014.01.003     Document Type: Article

References (16)

1. R. Martin, H.F. McFarland, and D.E. McFarlin Immunological aspects of demyelinating diseases Annu Rev Immunol 10 1992 153 187
2. International Multiple Sclerosis Genetics Consortium, Wellcome Trust Case Control Consortium 2, S. Sawcer, G. Hellenthal, M. Pirinen, C.C. Spencer, N.A. Patsopoulos, and L. Moutsianas et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis Nature 476 2011 214 219
3. C. Cotsapas, B.F. Voight, E. Rossin, K. Lage, B.M. Neale, and C. Wallace et al. Pervasive sharing of genetic effects in autoimmune disease PLoS Genet 7 2011 e1002254 10.1371/journal.pgen.1002254
4. H. Roshanisefat, S. Bahmanyar, J. Hillert, T. Olsson, and S. Montgomery Shared genetic factors may not explain the raised risk of co morbid inflammatory diseases in multiple sclerosis Mult Scler J 18 2012 1430 1436
5. T. Kwok, W. Jing Loo, and L. Guenther Psoriasis and multiple sclerosis: is there a link? J Cutan Med Surg 14 2010 151 155
6. K. Ghoreschi, J. Bruk, C. Kellerer, C. Deng, H. Peng, and O. Rothfuss et al. Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells J Exp Med 208 2011 2291 2303
7. L.F. Barcellos, B.B. Kamdar, P.P. Ramsay, C. DeLoa, R.R. Lincoln, and S. Caillier et al. Clustering of autoimmune diseases in families with a high-risk for multiple sclerosis: a descriptive study Lancet Neurol 5 2006 924 931
8. E.C. Somers, S.L. Thomas, L. Smeeth, and A.J. Hall Autoimmune diseases co-occurring within individuals and within families: a systematic review Epidemiology 17 2006 202 217
9. A. Karni, and O. Abramsky Association of MS with thyroid disorders Neurology 53 1999 883 885
10. K. Ghoreschi, C. Weigert, and M. Röcken Immunopathogenesis and role of T cells in psoriasis Clin Dermatol 25 2007 574 580
11. R. Gold, L. Kappos, D.L. Arnold, A. Bar-Or, G. Giovannoni, and K. Selmaj et al. Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis N Engl J Med 367 2012 1098 1107
12. M. Rostami Yazdi, and U. Mrowietz Fumaric acid esters Clin Dermatol 26 2008 522 526
13. L. La Mantia, and F. Capsoni Psoriasis during interferon beta treatment for multiple sclerosis Neurol Sci 31 2010 337 339
14. J. Antel, S. Antel, Z. Caramanos, D.L. Arnold, and T. Kuhlmann Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity? Acta Neuropathol 123 2012 627 638
15. R. Parisi, D.P. Symmons, C.E. Griffiths, and D.M. Ashcroft Identification and Management of Psoriasis and Associated ComorbidiTy (IMPACT) project team. Global epidemiology of psoriasis: a systematic review of incidence and prevalence J Invest Dermatol 133 2013 377 385
16. R. Dobson, and G. Giovannoni Autoimmune disease in people with multiple sclerosis and their relatives: a systematic review and meta-analysis J Neurol 260 2013 1272 1285